Reports

This summary of eye and tissue donation activity presents a series of graphs and tables compiled from data reported by contributing banks across Australia. This report supersedes previous data reported.

Living kidney donation activity for Australia and New Zealand, April 2026. This report supersedes previously published data reported by contributing Renal units.

This summary provides an overview of organ donation activity in Australia for the current calendar year.  It includes a series of tables and graphs detailing data by state and jurisdiction. This report supersedes previous data reported.

This report presents the results of a 2025 survey of haemodialysis capacity conducted by the Australian and New Zealand Society of Nephrology (ANZSN), the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, and the New Zealand National Clinical Renal Network. The survey covers all haemodialysis units in Australia and Aotearoa New Zealand.Haemodialysis is the most common form of kidney replacement therapy in Australia and Aotearoa New Zealand, most often delivered in hospital or satellite dialysis centres. Because treatments are frequent and lengthy, access to services reasonably close to where people live is important. Adequate capacity depends on sufficient machines, staff, and physical space.The report details patient-to-machine ratios across capital cities and regions, identifies where machines are non-functional due to staffing or funding constraints, and documents waiting lists for haemodialysis access. Key findings include waiting lists in more than 80% of Australian regions, machines out of service in 24% of Australian units, and several jurisdictions operating above usual capacity levels, with particular pressure in regional and remote areas.

This summary of eye and tissue donation activity presents a series of graphs and tables compiled from data reported by contributing banks across Australia. This report supersedes previous data reported.

We are pleased to announce the release of the 2026 ANZOD Annual Report, which reflects data collected up to December 2025. This year's report includes detailed chapters and supplementary tables that outline organ donation and transplantation activity for the year.Throughout 2025, the ANZOD Annual Report underwent a significant review by our working group. This marks the first release of the ANZOD Annual Report in this revised format. The review focused on streamlining chapters to align with current practices, providing a comprehensive view of longitudinal data where applicable, and offering a deeper insight into donor characteristics.We are excited to present this updated report and invite you to explore its findings.

Living kidney donation activity for Australia and New Zealand, March 2026. This report supersedes previously published data reported by contributing Renal units.

This summary provides an overview of organ donation activity in Australia for the current calendar year.  It includes a series of tables and graphs detailing data by state and jurisdiction. This report supersedes previous data reported.

This summary of eye and tissue donation activity presents a series of graphs and tables compiled from data reported by contributing banks across Australia. This report supersedes previous data reported.

Living kidney donation activity for Australia and New Zealand, February 2026. This report supersedes previously published data reported by contributing Renal units.

This summary provides an overview of organ donation activity in Australia for the current calendar year.  It includes a series of tables and graphs detailing data by state and jurisdiction. This report supersedes previous data reported.

A reporting arrangement of ANZSN and ANZDATA, this report provides additional information to units on quality indicators. Data is provided as it is reported to ANZDATA and is a representation of the Real-time Database for the period of 2025.  The results are preliminary and subject to change with the subsequent report from the Analysis database in September, providing the final results for the 2025 observation period. Units should use these data to monitor clinical practice and outcomes.